| US: HIPAA and tracking | HHS’s guidance on online tracking technologies warns that pixels and tags on booking pages, patient portals and logged-in areas can send protected health information to vendors such as ad platforms. A 2024 court ruling narrowed the part about ordinary public pages, so check with your regulator or adviser on the current position; booking flows and portals are still the risky part. | No marketing pixels on booking, forms, portal or condition pages, analytics set up without personal details, and booking handled by a system that will sign a business associate agreement. |
| US: Section 1557 | Under Section 1557 of the Affordable Care Act, covered providers must not discriminate, and HHS’s 2024 rule asks for a notice of nondiscrimination and a notice of free language help, including on the website. Parts of that rule are being challenged in court, so check with your regulator on what applies to you now. | A non-discrimination page and language-assistance taglines linked from every footer, ready to update when the rule settles. |
| US: No Surprises Act | Uninsured and self-pay patients have the right to a good faith estimate of expected charges when they book at least three business days ahead or ask for one, and can dispute a bill $400 or more above it. CMS’s provider pages explain the notice you must make available, including on your website. | A good faith estimate notice next to self-pay and cash prices, and an estimate request that does not ask for more health detail than needed. |
| US: accessibility and claims | The DOJ’s web accessibility rule sets WCAG 2.1 AA for state and local government services, including public hospital clinics. Private clinics have no fixed technical standard under the ADA, but web accessibility claims are common. The FTC’s Endorsement Guides mean testimonials cannot make claims you could not make yourself, and health claims need evidence. State medical boards add their own advertising rules. | WCAG 2.1 AA from day one, an accessibility statement, and copy checked for claims you can back up. |
| UK: CQC and regulators | Under Regulation 20A, a provider with a CQC rating must show its latest rating and a link to the report on its website. CQC’s display guidance says how; the widget is the easiest route. Unrated providers are exempt. Scotland (Healthcare Improvement Scotland), Wales (HIW) and Northern Ireland (RQIA) have their own regulators, so check with your regulator on what to display. | The CQC widget in the header or footer of every page, or the right regulator details for your nation, and a rating that updates itself. |
| UK: medicines and aesthetics | The CAP Code and the Human Medicines Regulations ban advertising prescription-only medicines to the public. The ASA’s guidance on botulinum toxin says not to name Botox or similar medicines on home pages, in logos, in testimonials or in ads, and to promote the consultation instead. The GMC’s Good medical practice expects information about your services to be honest and checkable. | Aesthetics menus built around concerns and consultations, no medicine names in headings, logos or offers, and clinician cards with GMC, HCPC or NMC numbers. |
| Canada | The CPSO’s advertising policy in Ontario bans testimonials and superlative or comparative claims. The CPSBC standard in British Columbia bans superiority claims and asks that services not covered by MSP are clearly identified. The CPSA standard in Alberta bans testimonials and endorsements. In Quebec, the CMQ sets its own rules and the Charter of the French Language expects a full French site. Other professions and provinces differ, so check with your college. | No testimonials or “best” claims on physician sites, uninsured fees shown clearly, a register link for each physician, and full French versions in Quebec. |
| Australia | AHPRA’s advertising guidelines ban testimonials about clinical aspects of care and restrict “specialist” to specialist-registered practitioners. Its guidelines for non-surgical cosmetic procedures go further for higher-risk procedures: no testimonials, strict rules for before-and-after images, and no images of under-18s. The Therapeutic Goods Act and TGA rules restrict advertising prescription-only medicines to the public. Check with AHPRA and the TGA for the current wording. | No clinical testimonials or review widgets on the site by default, cosmetic pages without medicine names, and before-and-after pages that follow the image rules. |